Skip to main content
Top
Published in: Current Rheumatology Reports 12/2023

22-09-2023 | Systemic Lupus Erythematosus

Possible Role of Dysbiosis of the Gut Microbiome in SLE

Authors: F. Naz Cemre Kalayci, Seza Ozen

Published in: Current Rheumatology Reports | Issue 12/2023

Login to get access

Abstract

Purpose of Review

The resident gut microbiota serves as a double-edged sword that aids the host in multiple ways to preserve a healthy equilibrium and serve as early companions and boosters for the gradual evolution of our immune defensive layers; nevertheless, the perturbation of the symbiotic resident intestinal communities has a profound impact on autoimmunity induction, particularly in systemic lupus erythematosus (SLE). Herein, we seek to critically evaluate the microbiome research in SLE with a focus on intestinal dysbiosis.

Recent Findings

SLE is a complex and heterogeneous disorder with self-attack due to loss of tolerance, and there is aberrant excessive immune system activation. There is mounting evidence suggesting that intestinal flora disturbances may accelerate the formation and progression of SLE, presumably through a variety of mechanisms, including intestinal barrier dysfunction and leaky gut, molecular mimicry, bystander activation, epitope spreading, gender bias, and biofilms.

Summary

Gut microbiome plays a critical role in SLE pathogenesis, and additional studies are warranted to properly define the impact of gut microbiome in SLE, which can eventually lead to new and potentially safer management approaches for this debilitating disease.
Literature
21.••
go back to reference Hevia A, Milani C, Lopez P, Cuervo A, Arboleya S, Duranti S, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. Mbio. 2014;5(5). https://doi.org/10.1128/mBio.01548-14. For the first time, next-generation sequencing approaches are used to characterize intestinal dysbiosis linked to SLE. Hevia A, Milani C, Lopez P, Cuervo A, Arboleya S, Duranti S, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. Mbio. 2014;5(5). https://​doi.​org/​10.​1128/​mBio.​01548-14. For the first time, next-generation sequencing approaches are used to characterize intestinal dysbiosis linked to SLE.
77.
go back to reference Posadas-Romero C, Torres-Tamayo M, Zamora-Gonzalez J, Aguilar-Herrera BE, Posadas-Sanchez R, Cardoso-Saldana G, et al. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum. 2004;50(1):160–5. https://doi.org/10.1002/art.11472.CrossRefPubMed Posadas-Romero C, Torres-Tamayo M, Zamora-Gonzalez J, Aguilar-Herrera BE, Posadas-Sanchez R, Cardoso-Saldana G, et al. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum. 2004;50(1):160–5. https://​doi.​org/​10.​1002/​art.​11472.CrossRefPubMed
84.
go back to reference Rodriguez-Carrio J, Lopez P, Sanchez B, Gonzalez S, Gueimonde M, Margolles A, et al. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus. Frontiers in Immunology. 2017;8. https://doi.org/10.3389/fimmu.2017.00023. Rodriguez-Carrio J, Lopez P, Sanchez B, Gonzalez S, Gueimonde M, Margolles A, et al. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus. Frontiers in Immunology. 2017;8. https://​doi.​org/​10.​3389/​fimmu.​2017.​00023.
87.••
go back to reference Greiling TM, Dehner C, Chen X, Hughes K, Iñiguez AJ, Boccitto M, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med. 2018;10(434). https://doi.org/10.1126/scitranslmed.aan2306. This study suggested that Ro60 ortholog-producing commensal species may initiate and also maintain autoimmunity in lupus in genetically predisposed individuals via a molecular mimicry mechanism. Greiling TM, Dehner C, Chen X, Hughes K, Iñiguez AJ, Boccitto M, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med. 2018;10(434). https://​doi.​org/​10.​1126/​scitranslmed.​aan2306. This study suggested that Ro60 ortholog-producing commensal species may initiate and also maintain autoimmunity in lupus in genetically predisposed individuals via a molecular mimicry mechanism.
99.
go back to reference Bellocchi C, Fernández-Ochoa Á, Montanelli G, Vigone B, Santaniello A, Quirantes-Piné R, et al. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases. J Clin Med. 2019;8(9). https://doi.org/10.3390/jcm8091291. Bellocchi C, Fernández-Ochoa Á, Montanelli G, Vigone B, Santaniello A, Quirantes-Piné R, et al. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases. J Clin Med. 2019;8(9). https://​doi.​org/​10.​3390/​jcm8091291.
103.•
go back to reference Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, et al. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol. 2021;73(2):232–43. https://doi.org/10.1002/art.41511. This research study offers comprehensive insights into the microbiota composition of individuals with untreated SLE by examining the functional characteristics of the microbiota and the identification of peptides that mimic autoantigens.CrossRefPubMed Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, et al. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol. 2021;73(2):232–43. https://​doi.​org/​10.​1002/​art.​41511. This research study offers comprehensive insights into the microbiota composition of individuals with untreated SLE by examining the functional characteristics of the microbiota and the identification of peptides that mimic autoantigens.CrossRefPubMed
126.
go back to reference Nockher WA, Wigand R, Schoeppe W, Scherberich JE. Elevated levels of soluble cd14 in serum of patients with systemic lupus-erythematosus. Clin Exp Immunol. 1994;96(1):15–9.CrossRefPubMedPubMedCentral Nockher WA, Wigand R, Schoeppe W, Scherberich JE. Elevated levels of soluble cd14 in serum of patients with systemic lupus-erythematosus. Clin Exp Immunol. 1994;96(1):15–9.CrossRefPubMedPubMedCentral
129.
go back to reference Thim-uam A, Surawut S, Issara-Amphorn J, Jaroonwitchawan T, Hiengrach P, Chatthanathon P, et al. Leaky-gut enhanced lupus progression in the Fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus. Scientific Reports. 2020;10(1). https://doi.org/10.1038/s41598-019-57275-0. Thim-uam A, Surawut S, Issara-Amphorn J, Jaroonwitchawan T, Hiengrach P, Chatthanathon P, et al. Leaky-gut enhanced lupus progression in the Fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus. Scientific Reports. 2020;10(1). https://​doi.​org/​10.​1038/​s41598-019-57275-0.
132.
go back to reference Shoenfeld Y, Vilner Y, Coates AR, Rauch J, Lavie G, Shaul D, et al. Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol. 1986;66(2):255–61.PubMedPubMedCentral Shoenfeld Y, Vilner Y, Coates AR, Rauch J, Lavie G, Shaul D, et al. Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol. 1986;66(2):255–61.PubMedPubMedCentral
Metadata
Title
Possible Role of Dysbiosis of the Gut Microbiome in SLE
Authors
F. Naz Cemre Kalayci
Seza Ozen
Publication date
22-09-2023
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 12/2023
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-023-01115-8

Other articles of this Issue 12/2023

Current Rheumatology Reports 12/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare